Pentwater Capital Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Pentwater Capital Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,080,507	Closed	-$50.2M	–	156
2023 Q2	$50.2M	Buy	+1,080,507	New	+$37.3M	0.35%	41

Pentwater Capital Management's DICE Position: Q3 2023 in Review

Pentwater Capital Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 1,080,507 shares — an estimated $50.2M sold.

Pentwater Capital Management first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $50.2M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Pentwater Capital Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Pentwater Capital Management sold 1,080,507 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $50.2M.
Pentwater Capital Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Pentwater Capital Management's DICE Therapeutics, Inc. Common Stock position peaked at $50.2M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Pentwater Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.